Altınörs Dilek D, Asena Leyla
From the Department of Ophthalmology, Baskent University Faculty of Medicine, Ankara, Turkey.
Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):101-103. doi: 10.6002/ect.TOND-TDTD2017.O38.
We aimed to report the clinical outcomes of Descemet membrane endothelial keratoplasty in our first year of experience.
Patients who underwent Descemet membrane endothelial keratoplasty at the Baskent University Faculty of Medicine, Department of Ophthalmology, between 2015 and 2016 were included in the study. Patient demographics, cause of endothelial dysfunction, best-corrected visual acuity, central corneal thickness, graft survival, follow-up duration, and intraoperative and postoperative complications were recorded.
Five eyes of 5 patients (4 female, 1 male) with a mean age of 53.4 ± 12.7 years were included. Cause of endothelial dysfunction included corneal endothelial dystrophy in 3 patients, pseudophakic bullous keratopathy in 1 patient, and endothelial graft failure after previous penetrating keratoplasty in 1 patient. Pre-stripped Descemet membranes obtained from the Ankara State Hospital Eye Bank were used. Mean duration of postoperative follow-up was 7.4 ± 3.7 months. Mean preoperative Snellen best-corrected visual acuity and central corneal thickness were 0.24 ± 0.15 and 625.5 ± 97.4 μm. Mean best-corrected visual acuity increased to 0.67 ± 0.26 (P = .02) in the first month and to 0.84 ± 0.11 (P < .01) at the end of follow-up. Mean central corneal thickness decreased to 546.6 ± 28.4 μm (P = .03). Graft detachment was observed in 1 patient on the first postoperative day, and it was reattached successfully by injection of air into the anterior chamber. There were no intraoperative complications. All corneas were clear at the end of follow-up.
Descemet membrane endothelial keratoplasty provides a new and exciting option for endothelial transplant and has the potential to become the primary procedure for surgical management of Fuchs endothelial dystrophy and corneal endothelial disease. Rapid visual rehabilitation with few and manageable complications and good visual outcomes are the major advantages of this procedure.
我们旨在报告在开展Descemet膜内皮角膜移植术的第一年中的临床结果。
纳入2015年至2016年间在巴斯肯特大学医学院眼科接受Descemet膜内皮角膜移植术的患者。记录患者的人口统计学资料、内皮功能障碍的病因、最佳矫正视力、中央角膜厚度、植片存活率、随访时间以及术中及术后并发症。
纳入5例患者的5只眼(4例女性,1例男性),平均年龄53.4±12.7岁。内皮功能障碍的病因包括3例角膜内皮营养不良、1例人工晶状体眼大泡性角膜病变以及1例既往穿透性角膜移植术后内皮植片失败。使用从安卡拉国家医院眼库获取的预剥离Descemet膜。术后平均随访时间为7.4±3.7个月。术前平均Snellen最佳矫正视力和中央角膜厚度分别为0.24±0.15和625.5±97.4μm。第一个月时平均最佳矫正视力增至0.67±0.26(P = 0.02),随访结束时增至0.84±0.11(P < 0.01)。平均中央角膜厚度降至546.6±28.4μm(P = 0.03)。1例患者在术后第一天出现植片脱离,通过向前房内注入空气成功复位。术中无并发症。随访结束时所有角膜均透明。
Descemet膜内皮角膜移植术为内皮移植提供了一种新的、令人兴奋的选择,并且有可能成为治疗Fuchs内皮营养不良和角膜内皮疾病的主要手术方式。该手术的主要优点是视力快速恢复,并发症少且易于处理,视觉效果良好。